AVE 0.00% 0.2¢ avecho biotechnology limited

POH are solidly and consistently moving forward to commercialize...

  1. 10,009 Posts.
    POH are solidly and consistently moving forward to commercialize a seven day OXYPATCH that is abuse proof and very effective chronic pain treatment.

    This will be a world first for opiod drugs and a Blockbuster for POH. We ill own it a 100 percent and the sales potential is a bout 5 billion globally.

    Whilst we own it better than 60 % of revenue will flow back to POH coffers. This is a company maker and we are getting very close.

    PoS
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
0.000(0.00%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.2¢ 0.2¢ 0.2¢ $973 486.2K

Buyers (Bids)

No. Vol. Price($)
11 6361102 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 41925822 29
View Market Depth
Last trade - 10.27am 31/10/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.